U.S. Supreme Court

Case Status


Docket Number


2019 Term


Questions Presented

Whether the Eighth Circuit erred in holding that Arkansas's statute regulating PBMs' drug-reimbursement rates, which is similar to laws enacted by a substantial majority of States, is preempted by ERISA, in contravention of this Court's precedent that ERISA does not preempt rate regulation.

Case Updates

U.S. Supreme Court holds that ERISA does not preempt state law regulating the prices that pharmaceutical benefit managers pay pharmacies for prescription drugs

December 10, 2020

Click here to view the opinion. The U.S. Chamber filed a coalition amicus brief at the merits stage supporting preemption.

U.S. Chamber files coalition amicus brief urging Supreme Court to reject unduly narrow, counter-textual approach to ERISA preemption

April 01, 2020

Click here to view the amicus brief filed by the U.S. Chamber and American Benefits Council. Helgi C. Walker of Gibson, Dunn & Crutcher LLP served as co-counsel for the amici.

Case Documents